Monte Rosa Therapeutics I... (GLUE)
undefined
undefined%
At close: undefined
7.60
0.86%
After-hours Dec 13, 2024, 06:37 PM EST

Ratios (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -0.54 -0.86 -3.30 -6.46 -29.06
PS Ratio 0.00 0.00 0.00 0.00 0.00
PB Ratio 0.41 0.33 0.68 -4.78 -19.18
P/FCF Ratio -1.16 -0.85 -3.44 -8.81 -30.83
P/OCF Ratio -1.66 -0.97 -4.00 -10.11 -37.74
OCF/S Ratio 0.00 0.00 0.00 0.00 0.00
Debt / Equity Ratio 0.00 0.00 0.00 -0.35 -0.02
Quick Ratio 1.27 2.69 5.24 0.37 0.57
Current Ratio 1.27 2.70 5.24 0.37 0.57
Asset Turnover 0.00 0.00 0.00 0.00 0.00
Interest Coverage 0.00 -7.46 0.00 0.00 -1998.50
Return on Equity (ROE) -75.51% -38.55% -20.70% 74.02% 65.99%
Return on Assets (ROA) -44.56%-30.56%-19.64%-73.04%-72.26%
Return on Capital (ROIC) -55.73%-35.47%-20.84%-139.33%-117.52%
Dividend Yield 0.00%0.00%0.00%0.00%0.00%
Payout Ratio 0.00% 0.00% 0.00% 0.00% 0.00%
Gross Profit Margin 0.00% 0.00% 0.00% 0.00% 0.00%
Net Profit Margin 0.00% 0.00% 0.00% 0.00% 0.00%